Monaco

Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days

Retrieved on: 
Monday, November 6, 2023

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced that RC Consulting Group LLC (“RC”) has advised that the final phase for the withdrawal/payment to Novo of the unsecured 15-year $70,000,000 promissory note with RC in favor of SCP Tourbillion Monaco for a lump sum debt funding of $57,000,000, less fees and expenses, has been initiated and is expected to be completed within the next 3-5 business days.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced that RC Consulting Group LLC (“RC”) has advised that the final phase for the withdrawal/payment to Novo of the unsecured 15-year $70,000,000 promissory note with RC in favor of SCP Tourbillion Monaco for a lump sum debt funding of $57,000,000, less fees and expenses, has been initiated and is expected to be completed within the next 3-5 business days.

Novo Integrated Sciences’ Board of Directors Approves $5 Million Stock Repurchase Program

Retrieved on: 
Tuesday, October 24, 2023

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company’s Board of Directors has approved the repurchase of up to $5 million of the Company's outstanding common stock ("shares") from time to time in the open market at prevailing market prices or in privately negotiated transactions.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company’s Board of Directors has approved the repurchase of up to $5 million of the Company's outstanding common stock ("shares") from time to time in the open market at prevailing market prices or in privately negotiated transactions.
  • The repurchase program does not obligate the Company to acquire any particular number of shares, and the repurchase program may be discontinued at any time at the Company's discretion.
  • Robert Mattacchione, Novo’s CEO and Chairman of the Board, stated, "Today's announcement conveys our ongoing confidence in our business and dedication to enhancing stockholder value.
  • This stock repurchase program is a direct reflection of our belief that our shares are undervalued, and a demonstration of our confidence in the business and the long-term opportunity ahead."

Novo Integrated Sciences Provides Update on Certain Current Events

Retrieved on: 
Friday, October 6, 2023

Upon completion of the Collateral transfer, the Company expects to leverage the Collateral in order to obtain a significant line of credit.

Key Points: 
  • Upon completion of the Collateral transfer, the Company expects to leverage the Collateral in order to obtain a significant line of credit.
  • The line of credit would be secured solely by the Collateral, leaving the balance of the Company’s assets free and clear.
  • Upon successful monetization, the Company will advance the prescribed fee of 15% of the monetization amount to Blacksheep Trust.
  • In short order Novo Integrated Sciences Inc. will be granted the right of first draw against the coupon resulting in a more significant role for RC as it relates to ensuring a good compliance standing.

Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon

Retrieved on: 
Thursday, August 31, 2023

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company received an Underwriting Clearance Notice from RC Consulting Group LLC informing Novo that the underwriting analysis process and compliance review for the transaction between Novo and RC Consulting LLC in favor of SCP Tourbillion Monaco (the “Buyer”), dated April 26, 2023, has been affirmed and approved for completion resulting in the recommendation to proceed with the transaction as contemplated.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company received an Underwriting Clearance Notice from RC Consulting Group LLC informing Novo that the underwriting analysis process and compliance review for the transaction between Novo and RC Consulting LLC in favor of SCP Tourbillion Monaco (the “Buyer”), dated April 26, 2023, has been affirmed and approved for completion resulting in the recommendation to proceed with the transaction as contemplated.
  • The affirming position has resulted in a “Clear to Close” status for the transaction of an unsecured 15-year $70,000,000 promissory note with the Buyer for debt funding of $57,000,000.
  • The note provides for a yield (non-compounding) of 1.52% (zero coupon) per annum and a maturity date 15 years from the date of issuance.
  • The Note is unsecured and there is no provision for the conversion of debt, issuance of any class of shares, or the grant of any warrants by the Company to the Buyer.

Owens Corning Appoints Nicolas Del Monaco President, Insulation

Retrieved on: 
Friday, August 25, 2023

Owens Corning (NYSE: OC) today announced that Nicolas Del Monaco has been appointed President of the company’s global Insulation business effective September 15, 2023.

Key Points: 
  • Owens Corning (NYSE: OC) today announced that Nicolas Del Monaco has been appointed President of the company’s global Insulation business effective September 15, 2023.
  • Mr. Del Monaco will succeed Todd Fister, who is transitioning to the role of Chief Financial Officer, as announced yesterday.
  • Mr. Del Monaco will report directly to Chair and Chief Executive Officer Brian Chambers and serve as a member of the company’s Executive Committee.
  • Mr. Del Monaco and his family will be relocating to the Toledo area from France.

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

Retrieved on: 
Tuesday, August 15, 2023

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:
    Parties continue to work toward closing SWAG Agreement: As previously disclosed, Novo entered into a share purchase agreement (the “SWAG Agreement”) with SwagCheck Inc. (“SWAG”) and the shareholders of SWAG, pursuant to which Novo agreed to purchase 100% of SWAG’s outstanding shares.
  • Although the SWAG Agreement has not yet closed, the parties continue to work together with the intention of closing the transaction.
  • The Company is expecting to receive an initial draw against the $57,000,000 in the near future.
  • The funding is expected to result in project-specific joint ventures for development of elder care and senior living community facilities in Canada.

Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results

Retrieved on: 
Monday, July 17, 2023

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the third fiscal quarter ended May 31, 2023.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the third fiscal quarter ended May 31, 2023.
  • During the fiscal year 2023 third quarter period, the Company announced the signing of agreements for an unsecured, non-dilutive 15-year debt instrument, with a principal sum of $70,000,000, which provides for the Company to receive net proceeds of approximately $55,000,000 after fees.
  • Revenues were $3,292,933, representing a decrease of $10,558,950, or 76%, from $13,851,883 for the same period in 2022.
  • Acenzia’s and Terragenx’s revenue for the three months ended May 31, 2023 was $896,405 and $5,866, respectively.

At the Monaco Energy Boat Challenge 2023 Italian team UniBoat wins the Energy Class

Retrieved on: 
Monday, July 10, 2023

MONACO, July 10, 2023 (GLOBE NEWSWIRE) -- The curtain falls on the 10th Monaco Energy Boat Challenge.

Key Points: 
  • MONACO, July 10, 2023 (GLOBE NEWSWIRE) -- The curtain falls on the 10th Monaco Energy Boat Challenge.
  • The winner of the Energy Class for the third year in a row is the Italian team UniBoat from Bologna University and in the Solar Class first place went to team Sunflare.
  • The winner of the Energy Class is the Italian team Uniboat of Bologna University.
  • “We consist of a team of 7 members and this is actually the fifth time that we won the Monaco Energy Boat Challenge in the Solar Class.

The Heart of Europe Monaco Hotel Enhances Guest Experience with Infor

Retrieved on: 
Monday, June 19, 2023

DUBAI, UAE, June 19, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that The Heart of Europe resort on Dubai World Islands is raising the bar for guest experience at its upscale Monaco Hotel using Infor Hospitality Management Solution (HMS) and Infor SCS Sales & Event Management software. 

Key Points: 
  • DUBAI, UAE, June 19, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that The Heart of Europe resort on Dubai World Islands is raising the bar for guest experience at its upscale Monaco Hotel using Infor Hospitality Management Solution (HMS) and Infor SCS Sales & Event Management software.
  • The Monaco Hotel, a  trendy 198-room hotel in The Heart of Europe, has deployed Infor's industry-specific HMS and will soon go live with the Infor SCS event management solution.
  • With Infor HMS, the Côte d'Azur Monaco Hotel can gather and use integrated, holistic data at multiple touchpoints to provide guests with a seamless, personalized, and consistent experience.
  • This improves guest experience while raising the productivity of hotel staff, who can re-allocate resources to more important tasks including enhancing customer service.

Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results

Retrieved on: 
Friday, May 26, 2023

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the fiscal quarter ended February 28, 2023.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the fiscal quarter ended February 28, 2023.
  • Robert Mattacchione, Novo’s CEO and Board Chairman, stated, “During the fiscal year 2023 second quarter period, the Company paid a total of $9,086,050 to certain note holders upon conversion of their notes.
  • Acenzia’s and Terragenx’s revenue for the three months ended February 28, 2023 was $458,920 and $32,167, respectively.
  • Net loss attributed to Novo Integrated Sciences, Inc. for the three months ended February 28, 2023 was $4,621,355, representing a decrease of $183,812, or 4%, from $4,805,167 for the same period in 2022.